Skip to content

Clinical trials

Phase 2 Leukemia, Lymphocytic, Chronic, B-Cell trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Lymphocytic, Chronic, B-Cell Phase: Phase 2 Country / region: Austria Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20041
20051
20061
20083
20121
20141
20161
20221
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated3
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
German CLL Study Group3
Biogen2
Hoffmann-La Roche2
AbbVie1
Arbeitsgemeinschaft medikamentoese Tumortherapie1
AstraZeneca1
Gilead Sciences1
MorphoSys AG1
TME Pharma AG1
University of Ulm1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Lymphocytic, Chronic, B-Cell14
Leukemia1
Leukemia, Large Granular Lymphocytic1
Leukemia, Prolymphocytic1
Neoplasms1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.